Mexican lawmakers were racing to meet an April 30 deadline to legalize cannabis for adult use. And then coronavirus hit.
New rules take effect April 1, including fewer barriers for doctors prescribing products, and available licenses for cultivators and manufacturers.
Parliamentary meetings, regulatory rule setting, and investment summits are being postponed, slowing what had been steady progress in the region.
As the virus took hold, the outlets were closed. But when street dealers quickly moved in, the government began to rethink the situation.
The government has also opened the door—part way—to banking licensed growers.
Three Senate committees approved a draft bill to legalize cannabis for medical, adult, and industrial use, kicking off a push toward an April deadline.
A global vote this week on the WHO’s position will be delayed. But here’s what the US (and other countries) have said so far.
Cannabis Wire reviewed a draft decision to delay until December the UN Commission on Narcotic Drugs vote on the World Health Organization’s recommendation to reschedule cannabis.
The National Commission on Marijuana, split on adult use legalization, puts the question to the public.
Lawmakers approved legislation to establish a Medicinal Cannabis Authority that would create licenses for everything from cultivation to consumption spaces.
While Saint Vincent expects a boost in cannabis revenue, US banking hurdles remain a major headache in the Caribbean.
A major union takes on labor law in the province where most of Canada’s product is grown.
Cannabis Wire reviewed a summary of the report sent to the prime minister that recommends both medical and adult use legalization.
The government wants to transition illegal cannabis growers into the legal industry, and to get exports underway.
The island will soon accept applications for medical cannabis cultivation licenses, but decriminalization will have to wait.